Table 2.
Pre-COVID-19 | COVID-19 | P | |
---|---|---|---|
Complementary tests | |||
1. Chest Radiography | 36 (24.7%) | 5 (18.5%) | 0.625 |
2. Blood test | 2 (1.4%) | 0 (0%) | 1 |
3. Pharyngeal or nasopharyngeal culture | 4 (2.7%) | 1 (3.7%) | 0.577 |
4. SARS-CoV-2 PCR test | 0 (0%) | 1 (3.7%) | |
Treatment | |||
1. Salbutamol | <0.001 | ||
Nebulizer | 133 (84.2%) | 7 (23.3%) | |
Inhaler | 5 (3.2%) | 11 (36.7%) | |
Direct at home | 20 (12.7%) | 12 (40%) | |
2. Ipratropium | 78 (49.4%) | 7 (23.3%) | 0.009 |
3. Steroids | 89 (56.3%) | 18 (60%) | 0.710 |
4. Antibiotic therapy | 31 (19.6%) | 7 (23.3%) | 0.891 |
5. Respiratory support With respiratory support: |
16 (10.1%) |
2 (6.67%) |
0.743 |
Oxygen (nasal or Ventimask) | 12 (7.59%) | 2 (6.67%) | |
OAF | 4 (2.53%) | 0 (0%) | |
VNI/VM | 0 (0%) | 0 (0%) |